Skip to main content
PMC home page
Gut logoLink to Gut
. 1991 Mar;32(3):260–265. doi: 10.1136/gut.32.3.260

A pilot study of fluticasone propionate in untreated coeliac disease.

H C Mitchison 1, H al Mardini 1, S Gillespie 1, M Laker 1, A Zaitoun 1, C O Record 1
PMCID: PMC1378830  PMID: 1901562

Abstract

Although gluten withdrawal is likely to remain the mainstay of treatment for adult coeliac disease, many patients find the diet inconvenient and unpalatable and compliance among asymptomatic patients is often poor. Oral corticosteroids have been used for patients who seem to be resistant to gluten withdrawal but preparations with low systemic bioavailability might be preferable. We have given a new glucocorticoid (fluticasone propionate) to 12 adults with untreated coeliac disease for six weeks while they were on a normal diet. One patient defaulted and one suffered a relapse in a pre-existing neoplasm. Excluding these, there was an improvement of symptoms, a mean weight gain of 2 kg, and a rise in albumin of 5.4 g/l. There was a significant improvement in the lactulose/mannitol excretion ratio (p less than 0.05) and in all histological variables examined in paired biopsy specimens (surface and crypt intraepithelial lymphocyte/enterocyte and goblet cell/enterocyte ratios and enterocyte height, p less than 0.01 or better). In six paired specimens sucrase and alkaline phosphatase activity increased in all (p less than 0.05) and lactase in five of six. No appreciable side effects were observed, but two patients had suppressed cortisol values and synacthen responses at six weeks. A further three, with normal pretrial results, had a blunted tetracosactrin response at six weeks. Fluticasone propionate seems worthy of further assessment in the treatment of coeliac disease as an adjunct to gluten withdrawal.

Full text

PDF
265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADLERSBERG D., COLCHER H., DRACHMAN S. R. Studies on the effects of cortisone and pituitary adrenocorticotropic hormone (ACTH) in the sprue syndrome. Gastroenterology. 1951 Dec;19(4):674–697. [PubMed] [Google Scholar]
  2. Bramble M. G., Watson A. J., Scott J., Peters T. J., Record C. O. Clinical, biochemical and morphological responses of patients with villous atrophy to oral betamethasone valerate and clobetasone butyrate. Digestion. 1981;22(6):281–288. doi: 10.1159/000198671. [DOI] [PubMed] [Google Scholar]
  3. Cobden I., Dickinson R. J., Rothwell J., Axon A. T. Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J. 1978 Oct 14;2(6144):1060–1060. doi: 10.1136/bmj.2.6144.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dahlqvist A. Assay of intestinal disaccharidases. Anal Biochem. 1968 Jan;22(1):99–107. doi: 10.1016/0003-2697(68)90263-7. [DOI] [PubMed] [Google Scholar]
  5. Dawson D. J., Lobley R. W., Burrows P. C., Notman J. A., Mahon M., Holmes R. Changes in jejunal permeability and passive permeation of sugars in intestinal biopsies in coeliac disease and Crohn's disease. Clin Sci (Lond) 1988 Apr;74(4):427–431. doi: 10.1042/cs0740427. [DOI] [PubMed] [Google Scholar]
  6. Hamilton J. D., Chambers R. A., Wynn-Williams A. Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease. Lancet. 1976 Jun 5;1(7971):1213–1216. doi: 10.1016/s0140-6736(76)92162-0. [DOI] [PubMed] [Google Scholar]
  7. Holmes G. K., Prior P., Lane M. R., Pope D., Allan R. N. Malignancy in coeliac disease--effect of a gluten free diet. Gut. 1989 Mar;30(3):333–338. doi: 10.1136/gut.30.3.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Howdle P. D., Corazza G. R., Bullen A. W., Losowsky M. S. Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change. Gastroenterology. 1981 Mar;80(3):442–450. [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Laker M. F. Estimation of disaccharides in plasma and urine by gas-liquid chromatography. J Chromatogr. 1979 May 1;163(1):9–18. doi: 10.1016/s0378-4347(00)81163-9. [DOI] [PubMed] [Google Scholar]
  11. Laker M. F., Mount J. N. Mannitol estimation in biological fluids by gas-liquid chromatography of trimethylsilyl derivatives. Clin Chem. 1980 Mar;26(3):441–443. [PubMed] [Google Scholar]
  12. Otaki A. T., Daly J. R., Morton-Gill A. Observations on oral betamethasone-17-valerate in the treatment of idiopathic steatorrhoea. Gut. 1967 Oct;8(5):458–462. doi: 10.1136/gut.8.5.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Peters T. J., Jones P. E., Jenkins W. J., Wells G. Analytical subcellular fractionation of jejunal biopsy specimens: enzyme activities, organelle pathology and response to corticosteroids in patients with non-responsive coeliac disease. Clin Sci Mol Med. 1978 Sep;55(3):293–300. doi: 10.1042/cs0550293. [DOI] [PubMed] [Google Scholar]
  14. Pickup M. E., Farah F., Lowe J. R., Dixon J. S., Record C. O. Prednisolone absorption in coeliac disease. Eur J Drug Metab Pharmacokinet. 1979;4(2):87–89. doi: 10.1007/BF03189406. [DOI] [PubMed] [Google Scholar]
  15. Riecken E. O., Stewart J. S., Booth C. C., Pearse A. G. A histochemical study on the role of lysosomal enzymes in idiopathic steatorrhoea before and during a gluten-free diet. Gut. 1966 Aug;7(4):317–332. doi: 10.1136/gut.7.4.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wall A. J., Douglas A. P., Booth C. C., Pearse A. G. Response of the jejunal mucosa in adult coeliac disease to oral prednisolone. Gut. 1970 Jan;11(1):7–14. doi: 10.1136/gut.11.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. YARDLEY J. H., BAYLESS T. M., NORTON J. H., HENDRIX T. R. Celiac disease. A study of the jejunal epithelium before and after a gluten-free diet. N Engl J Med. 1962 Dec 6;267:1173–1179. doi: 10.1056/NEJM196212062672303. [DOI] [PubMed] [Google Scholar]
  18. de Ritis G., Auricchio S., Jones H. W., Lew E. J., Bernardin J. E., Kasarda D. D. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology. 1988 Jan;94(1):41–49. doi: 10.1016/0016-5085(88)90607-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES